-
Zimmer Biomet in the 1st half of 2022: 8 notes
Zimmer Biomet has honed its position in spine and orthopedics in the first half of 2022. -
3Spine's clinical trial, Fuse Medical's partnership and more: 5 device company notes
A collaboration to develop implants and four more updates from spine devicemakers since June 29: -
Spine surgeon Selvon St. Clair debuts Surgalign system in Ohio
Selvon St. Clair, MD, PhD, performed the first case in Ohio using Surgalign's artificial intelligence and augmented reality system for spine surgery, Surgalign said July 6. -
Dr. Pawel Jankowski, Dr. Harvinder Bedi debut standalone cervical spacer
Pawel Jankowski, MD, and Harvinder Bedi, MD, performed the first cases with Additive Implants' SureMAX-SA standalone cervical spacer. -
Dr. Sigurd Berven debuts interbody fusion device
Sigurd Berven, MD, has completed the first clinical use of NovApproach Spine's OneLIF interbody fusion device. -
Medtronic's 1st half of 2022: 10 notes
Medtronic has had a busy first half of 2022 as it has built its leadership team, strengthened its portfolio through acquisitions and made strides in its spine technology. -
Spine devicemaker partners with manufacturer to develop implants
Fuse Medical and Oxford Performance Materials are partnering to develop spine and orthopedic implants with the OstepFab poly-ether-ketone-ketone technology. -
Spine company agrees to $1M settlement for surgeon kickback charges
Reliance Medical Systems, its owners and two of its physician-owned distributorships will pay a $1 million settlement to settle allegations they violated the False Claims Act by paying spine surgeons to use Reliance devices. -
ExplantLab develops algorithm that predicts joint replacement surgery outcome
Scientists from ExplantLab developed an algorithm that uses patient genotype and other factors to accurately predict joint replacement surgery outcomes, Genetic Engineering and Biotechnology News reported June 27. -
3Spine completes 1st US cases with Motus device
The first cases with 3Spine's Motus device for the lumbar spine were completed as part of an Investigational Device Exemption trial. -
Medtronic's spine implant, SeaSpine's interbody launch and more: 4 device company notes
SeaSpine's latest commercial launch and three other updates from spine devicemakers Becker's has covered since June 22: -
6 devicemaker acquisitions in Q2
From Conmed's $145 million deal to Stryker's orthopedic sale, here are six medtech acquisitions that closed or were announced in the second quarter of 2022. -
Medtronic board taps Pfizer executive as independent director
Medtronic named Lidia Fonseca as an independent director of its board of directors. -
California practice 1st on West Coast to add Globus' 3-in-1 spinal imaging system
DOCS Health in Los Angeles is the first West Coast facility to add Globus Medical's Excelsius3D system. -
Medtronic spine implant gets FDA clearance, breakthrough device designation
Medtronic has received FDA 510(k) clearance and breakthrough device designation for its LigaPass 2.0 ligament augmentation system. -
3Spine gets FDA exemption for implant trial
The FDA gave an investigational device exemption to spine devicemaker 3Spine. -
SeaSpine launches 1st 3D-printed cervical interbody
SeaSpine released its WaveForm C interbody system in a full commercial launch. -
AR spine navigation cleared, a spine robotics partnership and more: 5 device company notes
A devicemaker's spine surgery milestone and four more updates from medtech companies in the last week: -
Spine devicemaker surpasses 1,500 OLLIF cases
Inspired Spine reached more than 1,500 oblique lateral lumbar interbody spinal fusion procedures. -
Spine devicemaker, robotics company partner
Knoxville, Tenn.-based ChoiceSpine is partnering with France-based eCential Robotics to combine their technologies into one system.
Page 46 of 50